glp-1 gastroparesis lawsuit in kentucky drugs on Medicaid? Beshear and KY legislature disagree kentucky semaglutide stomach paralysis law

They will help determine which medication is best based on specific medical needs

Beyond glycemic control, GLP-1RA-induced weight loss, averaging 6.3 kg over 2452 weeks, confers additional metabolic advantages, including improved lipid profiles, reduced insulin resistance, and decreased hypertension, each of which plays a crucial role in the prevention of diabetic complications [84]

Weaknesses The lack of required baseline lab work is concerning from a medical safety perspective

GLP-1 RAs also delay gastric emptying, which contributes to satiety but may exacerbate symptoms in patients with pre-existing gastroparesis ( Additionally, weight loss with GLP-1 RAs is accompanied by reductions in lean mass, with skeletal muscle accounting for approximately 15%40% of total weight loss (Pandey et al., 2024

Semaglutide also slows gastric emptyingthe rate at which food moves from the stomach into the small intestineparticularly during early treatment

Med (Baltim)